首页> 外文期刊>Experimental Lung Research >Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer
【24h】

Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer

机译:台湾非吸烟女性肺癌的基因,途径和TF的综合分析

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The aim of this study was to investigate the molecular mechanism of lung cancer among nonsmoking Taiwan females. Materials and methods: By using the GSE19804 microarray data accessible from Gene Expression Omnibus (GEO) database, we identified differentially expressed genes (DEGs) between nonsmoking female lung cancer patients and healthy controls (!logFC! > 1.5 and p-value < 0.05). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene ontology (GO) enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID). The Search Tool for the Retrieval of Interacting Genes (STRING) tool was utilized to build a protein-protein interaction (PPI) network, followed by the construction of a transcriptional regulatory network based on Transcription factor (TRANSFAC) database. Results: As a result, 320 DEGs were identified between nonsmoking female patients with lung cancer and healthy controls. Pathway enrichment analysis showed significantly enriched pathways such as extracellular matrix (ECM)-receptor interaction and peroxisome proliferator-activated receptor (PPAR) signaling pathway, both of which were enriched with genes COL11A1 (encoding collagen XI alpha-1 chain protein), COL1A1, cluster of differentiation 36(CD36). GO enrichment analysis found that DEGs were significantly related to chemotaxis, vasculature development and cell adhesion GO terms. IL-6 was the node of the PPI network. Critical transcription factors (TFs) including CCAAT/enhancer-binding protein delta (CEBPD) and Rel/NF-kappa B were also identified. Conclusions: Our study revealed that ECM-receptor interaction, PPAR signaling pathways, and important biomolecules including COL11A1, COL1A1, CD36, IL-6, CEBPD, and Rel/NF-kappa B might be involved in lung cancer. This study might pave the way for the development and application of targeted therapeutics of lung cancer irrelevant to smoking.
机译:目的:本研究旨在调查台湾非吸烟女性肺癌的分子机制。材料和方法:通过使用可从基因表达综合(GEO)数据库访问的GSE19804微阵列数据,我们鉴定了非吸烟女性肺癌患者和健康对照之间的差异表达基因(DEG)(!logFC!> 1.5,p值<0.05) 。使用注释,可视化和综合发现数据库(DAVID)进行了《京都基因与基因组百科全书》(KEGG)途径和基因本体论(GO)富集分析。利用检索相互作用基因的搜索工具(STRING)工具来构建蛋白质-蛋白质相互作用(PPI)网络,然后基于转录因子(TRANSFAC)数据库构建转录调控网络。结果:结果,在非吸烟女性肺癌患者和健康对照之间鉴定出320 DEG。途径富集分析显示,细胞外基质(ECM)-受体相互作用和过氧化物酶体增殖物激活受体(PPAR)信号传导途径等途径均显着富集,二者均富含基因COL11A1(编码胶原XIα-1链蛋白),COL1A1,分化簇36(CD36)。 GO富集分析发现,DEG与趋化性,脉管系统发育和细胞粘附GO术语显着相关。 IL-6是PPI网络的节点。还确定了关键转录因子(TFs),包括CCAAT /增强子结合蛋白delta(CEBPD)和Rel /NF-κB。结论:我们的研究表明,ECM-受体相互作用,PPAR信号通路和重要的生物分子包括COL11A1,COL1A1,CD36,IL-6,CEBPD和Rel /NF-κB可能与肺癌有关。这项研究可能为与吸烟无关的肺癌靶向疗法的开发和应用铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号